125 related articles for article (PubMed ID: 10968405)
21. New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
Singh C; Chaudhary S; Puri SK
J Med Chem; 2006 Nov; 49(24):7227-33. PubMed ID: 17125275
[TBL] [Abstract][Full Text] [Related]
22. Novel saturated 1,2,4-trioxanes and their antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in Swiss mice model via oral route.
Kumari A; Yadav P; Rawat V; Maurya RA; Islam MS; Eldesoky GE; Puri SK; Verma VP
Bioorg Med Chem Lett; 2024 Aug; 108():129801. PubMed ID: 38777279
[TBL] [Abstract][Full Text] [Related]
23. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro.
Elueze EI; Croft SL; Warhurst DC
J Antimicrob Chemother; 1996 Mar; 37(3):511-8. PubMed ID: 9182108
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of antimalarial activity of arteether in combination with Vetiver root extract.
Dhawan S; Gunjan S; Pal A; Tripathi R
Indian J Exp Biol; 2016 May; 54(5):315-21. PubMed ID: 27319050
[TBL] [Abstract][Full Text] [Related]
25. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1997 Mar; 91(2):141-5. PubMed ID: 9307655
[TBL] [Abstract][Full Text] [Related]
26. [Tissue schizontocidal action and acute toxicity of trifluoroacetyl primaquine].
Ye XY; Shao BR
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):359-62. PubMed ID: 2104491
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
28. Assessment of pyronaridine activity in vivo and in vitro against the hepatic stages of malaria in laboratory mice.
Basco LK; Ringwald P; Franetich JF; Mazier D
Trans R Soc Trop Med Hyg; 1999; 93(6):651-2. PubMed ID: 10717758
[No Abstract] [Full Text] [Related]
29. [Determination of polyamines in pyronaridine-sensitive and -resistant Plasmodium berghei-infected erythrocytes].
Shi X; Ye X; Cai Y; Ha S; Yao J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(2):109-12. PubMed ID: 12078217
[TBL] [Abstract][Full Text] [Related]
30. Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice.
Karnatak M; Hassam M; Vanangamudi M; Sharma S; Kumar Yadav D; Singh C; Puri SK; Rawat V; Prakash Verma V
Bioorg Med Chem Lett; 2021 Nov; 51():128372. PubMed ID: 34547418
[TBL] [Abstract][Full Text] [Related]
31. New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: Synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Chaudhary S; Naikade NK; Tiwari MK; Yadav L; Shyamlal BRK; Puri SK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1536-1541. PubMed ID: 26898813
[TBL] [Abstract][Full Text] [Related]
32. [Stability of drug resistance of a pyronaridine-resistant line of Plasmodium berghei].
Shao BR; Ye XY; Zheng H
Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):183-05. PubMed ID: 2943123
[No Abstract] [Full Text] [Related]
33. Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Singh C; Kanchan R; Chaudhary S; Puri SK
J Med Chem; 2012 Feb; 55(3):1117-26. PubMed ID: 22216834
[TBL] [Abstract][Full Text] [Related]
34. [Residual blood schizontocidal activity of pyronaridine against rodent malaria].
Shao BR; Ye XY; Zheng H
Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):232-3, 242. PubMed ID: 6518633
[No Abstract] [Full Text] [Related]
35. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
36. [Toxicity and tissue schizontocidal activity of primaquine combined with pyronaridine in laboratory animals].
Shao BR; Zhan CQ; Chen KY; Ye XY; Lin BY; Ha SH; Shang YZ; Zhang JX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(1):22-5. PubMed ID: 3383390
[No Abstract] [Full Text] [Related]
37. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
[No Abstract] [Full Text] [Related]
38. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
40. Studies on a new antimalarial compound: pyronaridine.
Chang C; Lin-Hua T; Jantanavivat C
Trans R Soc Trop Med Hyg; 1992; 86(1):7-10. PubMed ID: 1566313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
